Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2024-11-28 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 109836

Date	Daily Closing Price	Open	High	Low	Volume
28 Thu Nov 2024	2413.60	2385.45	2435.40	2378.65	0.712 times
27 Wed Nov 2024	2385.45	2393.65	2413.40	2361.60	0.618 times
26 Tue Nov 2024	2393.65	2351.10	2424.90	2307.00	2.163 times
25 Mon Nov 2024	2341.65	2454.90	2486.85	2330.00	1.021 times
22 Fri Nov 2024	2411.80	2389.00	2439.90	2350.00	2.63 times
21 Thu Nov 2024	2369.65	2438.00	2449.60	2361.10	0.698 times
19 Tue Nov 2024	2438.00	2415.00	2478.45	2414.05	0.632 times
18 Mon Nov 2024	2411.65	2465.45	2485.50	2406.45	0.386 times
14 Thu Nov 2024	2457.15	2455.00	2491.00	2425.15	0.713 times
13 Wed Nov 2024	2452.70	2540.00	2540.10	2439.10	0.597 times

My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2396 as stoploss in an intra day buy trade for a target of 2515.15. However, stock will show a bearish move below 2396.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	2307.00
Upside Target	2425.15
Upside Target	2485.50
Upside Target	2676.25
Upside Target	2702.10
Upside Target	2733.10
Upside Target	2742.95
Upside Target	2763.00
Upside Target	2825.00
Upside Target	2889.90
Upside Target	2922.80
Upside Target	3088.00

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2318.12
Downside Intraday Target	2222.63
Upside Intraday Target	2497.97
Upside Intraday Target	2582.33
Downside Intraday Target	2402.48

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
28 Thu Nov 2024	2413.60	2454.90	2486.85	2307.00	1.039 times
22 Fri Nov 2024	2411.80	2465.45	2485.50	2350.00	1.852 times
14 Thu Nov 2024	2457.15	2575.25	2589.90	2425.15	0.527 times
08 Fri Nov 2024	2561.15	2733.10	2733.10	2550.50	1.036 times
01 Fri Nov 2024	2733.10	2588.60	2763.00	2536.70	0.97 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
28 Thu Nov 2024	2413.60	2729.00	2742.95	2307.00	0.832 times
31 Thu Oct 2024	2712.25	2751.00	2889.90	2500.00	1.386 times
30 Mon Sep 2024	2750.55	2751.85	2922.80	2676.25	0.476 times
30 Fri Aug 2024	2745.10	2740.00	3088.00	2702.10	0.885 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2403.73 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.